Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
-
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy
-
Clearmind Medicine Advances Fight Against Cocaine Addiction with Publication of U.S. Patent Application for Its Non-Hallucinogenic Neuroplastogen MEAI Therapy
-
RVC Zero Investment LP Announces Investment in Edge Copper Corporation
-
CN Declares Fourth-Quarter 2025 Dividend
-
Northfield and Juno Welcome Historic Webequie-Ontario Partnership Agreement Advancing Critical Ring of Fire Infrastructure
-
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
-
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
-
Birchtree Investments Announces Private Placement Closing
-
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
-
Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025
-
CN Delivers Strong Third Quarter Financial and Operating Results
-
TappAlpha’s TDAQ Surpasses $25 Million AUM in Under Two Months, Outpacing Nasdaq 100 in Performance
-
Stardust Power Fully Compliant with Nasdaq Listing Requirements
-
Creative Realities, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Information
-
Nasdaq Halts Premium Catering (Holdings) Limited
-
Fenix Outdoor: Quarter 3 report Fenix Outdoor International AG
-
Issue of Equity and Total Voting Rights
-
Acorn, Provider of Monitoring and Control Solutions for Power Generators, Hosts Q3 Earnings Call Thursday Nov. 6th at 11am ET
-
Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
-
OROCO RESOURCE CORP. PROVIDES FINANCING UPDATE
-
Taco John’s Offers Free Meals to Support Those Impacted by Shutdown
-
Costamare Inc. Sets the Date for Its Third Quarter 2025 Results Release, Conference Call and Webcast
-
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
-
Transaction in Own Shares
-
Is the Rental Market finally Cooling? Canada’s Rent Prices Dip as Immigration Slows
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
-
Falco Announces Extension of Its Senior Debts
-
BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers
-
September 2025 Quarterly Activities Report
-
Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award
-
Mesa Air Group enters into an Amendment to its Loan Agreement with the United States Treasury and Provides Update to its Pending Merger with Republic Airways
-
Perspective Therapeutics to Participate in Upcoming November Conferences
-
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorec
-
Upstream Bio to Participate in Upcoming November Investor Conferences
-
Castellum, Inc. Announces the Award of a $66.2 million Full and Open Contract to its SSI Subsidiary
-
AirSculpt Technologies Announces Third Quarter Fiscal 2025 Earnings Release Date and Conference Call
-
BNP Paribas Primary New Issues: POST-STAB Notice: No Stab - PCC GLOBAL PLC
-
PCCA UK Leadership Announcement
-
NANO Nuclear Senior Executives to Present at Upcoming November Nuclear Industry Conferences Including ADIPEC 2025, the World’s Largest Energy Conference
-
Carlyle Credit Income Fund Announces Private Placement of Convertible Preferred Shares
-
LyondellBasell reports third quarter 2025 earnings
-
Carlyle Secured Lending, Inc. Announces Intent to Redeem All Outstanding 8.20% Notes Due 2028
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Scandinavian Tobacco Group A/S: New employee-elected Board member
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Form 8.3 - Unite Group plc
-
Cenovus announces third-quarter 2025 results
-
Immuron Announces Clinical Trial Update
-
Hepsiburada to Announce Third Quarter 2025 Results on November 5, 2025
